The World Health Organization (WHO) recently warned that the global community is moving too slowly toward eliminating viral hepatitis. Although effective tools exist, the disease continues to kill over one million people every year. Specifically, viral hepatitis B and C account for 95 percent of all hepatitis-related deaths. Current data shows that 1.34 million lives were lost to these infections in 2024 alone. Furthermore, more than 1.8 million new infections are recorded annually.

Current Barriers to Eliminating Viral Hepatitis

Progress remains uneven across different regions and countries. Many patients do not receive a diagnosis or treatment because of social stigma. Furthermore, weak health systems and inequitable access to medicine hinder global efforts. WHO chief Tedros Adhanom Ghebreyesus emphasized that an urgent scale-up is required. He noted that while tools are available, they must reach those in need. Consequently, millions of people still live with chronic infections without medical support.

India is among the top six countries for hepatitis-related deaths. Other high-burden nations include China, Indonesia, Nigeria, South Africa, and Vietnam. In Africa, the situation is particularly concerning regarding newborn care. Only 17 percent of babies there received the hepatitis B birth vaccine dose in 2024. Additionally, only 5 percent of people with chronic hepatitis B receive treatment globally. However, some progress has occurred since 2015. For example, new hepatitis B infections dropped by 32 percent.

Effective Medical Tools for Disease Control

The tools to eliminate this public health threat are already in our hands. The hepatitis B vaccine provides more than 95 percent protection to recipients. This vaccine prevents both acute and chronic infections effectively. Moreover, long-term antiviral treatments help manage chronic hepatitis B and prevent liver cancer. For hepatitis C, short-course curative therapies are now available. These treatments last only eight to 12 weeks. They can cure more than 95 percent of infections. Therefore, sustaining political commitment is the primary requirement for success.

Frequently Asked Questions

Q1: Which countries have the highest number of hepatitis-related deaths?

Six countries account for a significant portion of global deaths. These include China, India, Indonesia, Nigeria, South Africa, and Vietnam.

Q2: Is there a cure available for hepatitis C?

Yes, hepatitis C can be cured. Short-course therapies lasting eight to 12 weeks have a cure rate of over 95 percent.

Q3: How effective is the hepatitis B vaccine?

The vaccine is highly effective. It protects more than 95 percent of recipients against developing acute and chronic infections.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. World going too slow on eliminating hepatitis: WHO - ETHealthworld


2. Global Hepatitis Report 2024 - World Health Organization


3. Hepatitis B and C: Global Progress and Challenges - Journal of Hepatology